Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Company profile
Ticker
ABT
Exchange
Website
CEO
Robert Ford
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Abbott Biologicals, LLC • Abbott Cardiovascular Inc. • Abbott Cardiovascular Systems Inc. • Abbott Delaware LLC • Abbott Diabetes Care Inc. • Abbott Diabetes Care Sales Corporation • Abbott Diagnostics Scarborough, Inc. • Abbott Equity Investments LLC • Abbott Finance LLC • Abbott Global LLC ...
IRS number
360698440
ABT stock data
Latest filings (excl ownership)
SD
Conflict minerals disclosure
30 May 24
10-Q
2024 Q1
Quarterly report
2 May 24
8-K
Departure of Directors or Certain Officers
1 May 24
8-K
Submission of Matters to a Vote of Security Holders
29 Apr 24
8-K
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
17 Apr 24
ARS
2023 FY
Annual report to shareholders
15 Mar 24
DEFA14A
Additional proxy soliciting materials
15 Mar 24
DEF 14A
Definitive proxy
15 Mar 24
10-K
2023 FY
Annual report
16 Feb 24
8-K
Entry into a Material Definitive Agreement
29 Jan 24
Transcripts
ABT
Earnings call transcript
2024 Q1
17 Apr 24
ABT
Earnings call transcript
2023 Q4
24 Jan 24
ABT
Earnings call transcript
2023 Q3
18 Oct 23
ABT
Earnings call transcript
2023 Q2
20 Jul 23
ABT
Earnings call transcript
2023 Q2
20 Jul 23
ABT
Earnings call transcript
2023 Q1
19 Apr 23
ABT
Earnings call transcript
2022 Q4
25 Jan 23
ABT
Earnings call transcript
2022 Q3
19 Oct 22
ABT
Earnings call transcript
2022 Q2
20 Jul 22
ABT
Earnings call transcript
2022 Q1
20 Apr 22
Latest ownership filings
4
Jr. Robert E. Funck,
14 May 24
144
Notice of proposed sale of securities
10 May 24
4
Lisa D Earnhardt
8 May 24
144
Notice of proposed sale of securities
7 May 24
4
John G Stratton
30 Apr 24
4
DANIEL J STARKS
30 Apr 24
4
Michael F Roman
30 Apr 24
4
Michael O'Grady
30 Apr 24
4
Nancy McKinstry
30 Apr 24
4
Darren W McDew
30 Apr 24
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 6.28 bn | 6.28 bn | 6.28 bn | 6.28 bn | 6.28 bn | 6.28 bn |
Cash burn (monthly) | 204.00 mm | 239.75 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 428.95 mm | 504.12 mm | n/a | n/a | n/a | n/a |
Cash remaining | 5.86 bn | 5.78 bn | n/a | n/a | n/a | n/a |
Runway (months of cash) | 28.7 | 24.1 | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2024
72.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 2749 |
Opened positions | 505 |
Closed positions | 201 |
Increased positions | 932 |
Reduced positions | 946 |
13F shares | Current |
---|---|
Total value | 137.07 tn |
Total shares | 1.26 bn |
Total puts | 8.66 mm |
Total calls | 8.41 mm |
Total put/call ratio | 1.0 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 165.30 mm | $18.79 tn |
BLK Blackrock | 133.08 mm | $15.13 tn |
Capital Research Global Investors | 83.98 mm | $9.55 tn |
STT State Street | 74.74 mm | $8.49 tn |
Capital International Investors | 70.18 mm | $7.98 tn |
MS Morgan Stanley | 36.01 mm | $4.09 tn |
Geode Capital Management | 33.73 mm | $3.82 tn |
Wellington Management | 28.26 mm | $3.21 tn |
NTRS Northern Trust | 21.02 mm | $2.39 tn |
WFC Wells Fargo & Co. | 16.79 mm | $1.91 tn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 May 24 | Robert E Funck | Common shares without par value | Sell | Dispose S | No | No | 104.5676 | 10,097 | 1.06 mm | 211,341 |
10 May 24 | Robert E Funck | Common shares without par value | Option exercise | Acquire M | No | No | 47 | 10,097 | 474.56 k | 221,438 |
10 May 24 | Robert E Funck | Option Common Shares | Option exercise | Dispose M | No | No | 47 | 10,097 | 474.56 k | 45,000 |
7 May 24 | Earnhardt Lisa D | Common shares without par value | Sell | Dispose S | No | No | 106.2541 | 22,852 | 2.43 mm | 61,462 |
26 Apr 24 | Alpern Robert J | Common shares without par value | Grant | Acquire A | No | No | 0 | 1,866 | 0.00 | 39,163 |
26 Apr 24 | Claire Babineaux-Fontenot | Common shares without par value | Grant | Acquire A | No | No | 0 | 1,866 | 0.00 | 3,682 |
26 Apr 24 | Blount Sally E. | Common shares without par value | Grant | Acquire A | No | No | 0 | 1,866 | 0.00 | 35,023 |
News
Goldman Sachs Initiates Coverage On Abbott Laboratories with Buy Rating, Announces Price Target of $121
30 May 24
8 Health Care Stocks Whale Activity In Today's Session
23 May 24
Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know
22 May 24
Citigroup Maintains Buy on Abbott Laboratories, Lowers Price Target to $119
22 May 24
Jim Cramer Calls This Healthcare Stock A 'Worthy Spec,' Recommends Avoiding Canada Goose
21 May 24
Press releases
Global Sports Nutrition Market Projected to Reach $78 Billion as Muscle Repair & Growth Becoming Vitally Important
21 May 24
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
29 Apr 24
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
17 Apr 24
Abbott Hosts Conference Call for First-Quarter Earnings
27 Mar 24
Beyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)
20 Mar 24